Coronary Artery Disease Clinical Trial
Official title:
A Lead Rectangle to Lower the Radiation Exposure for Operators Who Uses Radial Approach in Coronary Procedures.
During fluoroscopic imaging, diagnostic information is carried in the primary beam. These
high intensity X-rays are the chief hazard to the patient. Lower energy scattered radiation
deviates in all directions from the patient. Despite typical precautions (i.e., hanging a
lead shield between the patient and the operator), many operators will be exposed to high
radiation dose (higher than the permitted 50 miliS per year), this long term radiation
exposure may result in stochastic and deterministic effects. The purpose of this study was
to test the hypothesis that a non disposable radiation protection drape (that will cover the
lower part of the patient) could help minimize the radiation scattered from the patient to
the operator. In a procedure done through the Radial approach, there is a large portion of
the patients (from the umbilicus and down) that is a source of scatter radiation to the
operator. This portion can be covered with a lead rectangle. A non disposable, lead drape of
uniform thickness will be inserted into a sterile nylon bag and will be used during
fluoroscopic and cineangiography coronary angioplasty procedures. The lead drapes will cover
the femoral puncture site. The widths and length of the drape is 50-60cm and 100 cm
respectively and was shown not to hinder the field of radiation needed for fluoroscopy and
cineangiography. (The upper border of the lead is under the patient's umbilicus and was
shown not to interfere with the radiation field needed for angiography or angioplasty).
The Investigators anticipate that the study will show a significant reduction in radiation
exposure and hence reduce the radiation hazard to the operator.
The Investigators tested the hypothesis on a Phantom that contain bones and tissue that
simulate human tissue. The above phantom is used in the oncology department for testing
radiation protocols delivered to patients. Those preliminary testing showed that a lead
rectangle decreased significantly the radiation scattered towards the operators and
personnel in the catheterization laboratory. In all chosen places whether 40 or 100 cm from
the radiation beam - The Investigators detected a significant reduction in scattered
radiation. The significant reduction in these experiments is attributed to the location the
Investigators choose but also to the size of the lead drape 100 X60 cm which give a large
area of protection. From simple geometric calculations it's understandable that the zone or
volume of radiation protection become much larger further away from the lead
rectangle.Patients who are admitted for an elective PCI procedure ( or stable ACS patients)
will be ask to participate in the study and sign an informed consent. All the procedure will
be as standard of care, after cleaning the right or left arm, and the groin a sterile towel
will cover the groin, on top of the sterile towel the lead rectangle (that by itself will be
inserted to a sterile nylon bag) will be put over to cover the area from the umbilicus and
down.
(In case that the radial approach will fail and femoral approach will be needed, it is easy
to remove the lead rectangle while keeping sterile field in the groin area). Few dosimeters
will be used to assess radiation exposure, two underneath the lead apron, one on top, and
two dosimeters for the operator (two detecting the radiation exposure in the neck area).
The Investigators will approach patients in whom a long procedure time and higher radiation
exposure are anticipated (like patients with chronic total occlusion, heavily calcified or
tortuous coronary arteries). In those, the fluoroscopy time on average, is longer than
usual.
A total of 50 patients will be recruited (based on the Investigators preliminary radiation
testing on the phantom and the results of Politi et al). In 25 patients a lead rectangle
will be used on top of the regular protection (personal lead suit, leaded glass shield), in
25 patients only regular protection for the operators.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |